Capsida Biotherapeutics
Cell & Gene Therapy · Biotechnology

Capsida Biotherapeutics: Products & infrastructure

Capsida Biotherapeutics has 3 clinical trials on record, 0 under way.

Data updated Nov 21, 2026 · Back to the company report

Products

Capsida Biotherapeutics has 3 clinical trials on record, 0 under way.

3clinical trials
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov
A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease
phase 2 · stopped or withdrawn · GBA1 Parkinson Disease
Aug 2025
A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy
phase 2 · stopped or withdrawn · 1 participants · Developmental and Epileptic Encephalopathy
Jul 2025
Natural History Study in Pediatric Patients with STXBP1 Encephalopathy with Epilepsy
stopped or withdrawn · STXBP1 Encephalopathy with Epilepsy
Oct 2024
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.